Clinical Trial News and Research

RSS
First-in-human phase 0 study shows clinically-relevant activity of new drug in glioblastoma

First-in-human phase 0 study shows clinically-relevant activity of new drug in glioblastoma

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

New clinical trial evaluates aesthetic results of conservative surgery in breast cancer

New clinical trial evaluates aesthetic results of conservative surgery in breast cancer

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

NIH launches clinical trial to test infusions of combination antibodies in people with HIV

NIH launches clinical trial to test infusions of combination antibodies in people with HIV

Sesen Bio to present its three-month Phase 3 VISTA Trial data at Global Congress

Sesen Bio to present its three-month Phase 3 VISTA Trial data at Global Congress

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

Manx Telecom unveils MT clearSound that improves clarity of mobile phone calls

Manx Telecom unveils MT clearSound that improves clarity of mobile phone calls

Inflammation plays crucial role in preventing heart attacks and strokes, study reveals

Inflammation plays crucial role in preventing heart attacks and strokes, study reveals

Rice seeds could hold key to preventing HIV infections

Rice seeds could hold key to preventing HIV infections

Emergex signs MoU with Brazil’s Fiocruz for development of viral vaccines

Emergex signs MoU with Brazil’s Fiocruz for development of viral vaccines

First U.S. patient treated with innovative gene therapy at Bascom Palmer Eye Institute

First U.S. patient treated with innovative gene therapy at Bascom Palmer Eye Institute

Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer

Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer

Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia

Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia

Leading nutritionist explains about different types of iron in oral supplements

Leading nutritionist explains about different types of iron in oral supplements

Multi-year study data shows impact of new soft contact lens to slow myopia progression in children

Multi-year study data shows impact of new soft contact lens to slow myopia progression in children

AmpliPhi receives positive feedback from FDA for its AB-PA01 product targeting P.aeruginosa infections

AmpliPhi receives positive feedback from FDA for its AB-PA01 product targeting P.aeruginosa infections

TGen and PNOC take part in launch of NIH-supported Kids First Data Resource Portal

TGen and PNOC take part in launch of NIH-supported Kids First Data Resource Portal

Novel clinical trial to examine cannabis as potential treatment for essential tremor

Novel clinical trial to examine cannabis as potential treatment for essential tremor

Alcon expands its global support of eye care professionals through Alcon Experience Academy

Alcon expands its global support of eye care professionals through Alcon Experience Academy